OncoCyte Liquid Biopsies Cancer Diagnostics 2017

OncoCyte Corporation presents its liquid biopsy platform for next-generation cancer molecular diagnostics, addressing unmet needs in early and accurate cancer diagnosis. The company outlines plans to launch lung and breast confirmatory tests, supported by an experienced leadership team and core commercial and R&D capabilities.